# Clinical Characteristics of Primary Orthostatic Tremor – a Comprehensive Clinical Assessment of Patients in Sweden

**Authors:** Karolina af Edholm, Mathias Sundgren, Erik Fransén, Henrik Sjöström, Anders Svenningsson

PMC · DOI: 10.5334/tohm.1143 · 2026-03-05

## TL;DR

This study examines the clinical features of primary orthostatic tremor in Swedish patients, revealing common symptoms and the impact on daily life.

## Contribution

The study introduces and validates two new rating scales, OTIP and OT-10, for assessing disease severity in primary orthostatic tremor.

## Key findings

- OTIP and OT-10 scales were highly correlated with disease severity in POT patients.
- Upper limb tremors and mild Parkinsonian features were common in POT patients.
- Depression and anxiety symptoms were present in 25% of POT patients.

## Abstract

Primary orthostatic tremor (POT) is a rare neurological disease presenting as a bilaterally coherent tremor of 13–18 Hz and a subjective sensation of unsteadiness while standing. Patients are severely affected by the inability to stand and often eventually referred to walking aids and dependence on others.

This study aimed to investigate the clinical characteristics of POT in a Swedish patient population by interviews and questionnaires.

Patients with POT were recruited nationwide in Sweden. All participants underwent neurological examination, structured interview and evaluation according to nine standardized rating scales and questionnaires, including the novel orthostatic tremor scales OTIP and OT-10.

Fifty-two participants with EMG-verified POT were included in the final analysis. Disease duration was not significantly correlated to disease severity, while OTIP and OT-10 were highly correlated with severity of POT. Postural or action tremor in the arms were present in 58%. Mild signs of parkinsonism were common, and the combination of mild rigidity and bradykinesia was present in 25%. Symptoms of depression and anxiety were present in 25%. Although quality of life was often severely affected, 65% performed activities of daily life independently.

Patients with POT may be severely affected by their disease, independently of disease duration. Multiple associated symptoms like tremor in the upper extremities and mild Parkinsonian features need to be recognized by healthcare professionals.

52 patients with POT were clinically examined with rating scales and questionnaires. Additional symptoms like other tremors, parkinsonian signs, and depressive symptoms were common. Disease severity did not correlate to additional symptoms or disease duration. Questionnaires like OTIP and OT-10 can be recommended for assessment of disease severity.

## Linked entities

- **Diseases:** Primary orthostatic tremor (MONDO:0016546), depression (MONDO:0002050), anxiety (MONDO:0005618)

## Full-text entities

- **Genes:** HTT (huntingtin) [NCBI Gene 3064] {aka HD, IT15, LOMARS}
- **Diseases:** cerebellar infarctions (MESH:D007238), gait difficulties (MESH:D020234), Depression (MESH:D003866), neurological disease (MESH:D020271), falls (MESH:C537863), agoraphobia (MESH:D000379), thyroid disease (MESH:D013959), trigeminal neuralgia (MESH:D014277), muscle exhaustion (MESH:D006359), dementia (MESH:D003704), parkinsonism (MESH:D010302), migraine (MESH:D008881), goitre (MESH:D006042), rigidity (MESH:D009127), cerebellar atrophy (MESH:D002526), Tongue tremor (MESH:D014060), Orthostatic Tremor (MESH:C536418), inability to stand (MESH:C564980), Neurological (MESH:D009461), Restless legs (MESH:D012148), REM-sleep behaviour disorder (MESH:D020187), cognitive impairment (MESH:D003072), comatose (MESH:D003128), anxiety spectrum disorders (MESH:D001008), epilepsy (MESH:D004827), chorea (MESH:D002819), bradykinesia (MESH:D018476), Postural or action tremor (MESH:D014202), Parkinson's Disease (MESH:D010300), impaired mobility (MESH:D014086), head trauma (MESH:D006259), pain (MESH:D010146), physical (MESH:D059445), hypothyroid (MESH:D007037), fear of falling (MESH:C000719212), Guillan-Barre Syndrome (MESH:D020275), spinocerebellar ataxia (MESH:D020754), irritability (MESH:D001523), Corticobasal Degeneration (MESH:D000088282), cardiovascular disease (MESH:D002318), meningitis (MESH:D008580), Lewy Body Dementia (MESH:D020961), Anxiety (MESH:D001007), cortical atrophy (MESH:D001284), congenital facial hemiparesis (MESH:D010291), stuttering (MESH:D013342)
- **Chemicals:** Alcohol (MESH:D000438), gabapentin (MESH:D000077206), Perampanel (MESH:C551441), EQ5D (-), primidone (MESH:D011324), clonazepam (MESH:D002998), Propranolol (MESH:D011433)
- **Species:** Nicotiana tabacum (American tobacco, species) [taxon 4097], Homo sapiens (human, species) [taxon 9606]

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12962244/full.md

---
Source: https://tomesphere.com/paper/PMC12962244